Paradigm Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-4,100
| Closed | -$67.4K | – | 466 |
|
|
2017
Q2 | $67.4K | Sell |
4,100
-4,300
| -51% | -$70.7K | 0.01% | 478 |
|
|
2017
Q1 | $120K | Buy |
8,400
+300
| +4% | +$4.3K | 0.02% | 477 |
|
|
2016
Q4 | $112K | Sell |
8,100
-200
| -2% | -$2.77K | 0.02% | 382 |
|
|
2016
Q3 | $150K | Buy |
8,300
+300
| +4% | +$5.42K | 0.03% | 352 |
|
|
2016
Q2 | $115K | Buy |
+8,000
| New | +$115K | 0.02% | 413 |
|